JPMorgan Chase & Co. Analysts Give Swiss Re (SREN) a CHF 115 Price Target

Swiss Re (VTX:SREN) received a CHF 115 price objective from JPMorgan Chase & Co. in a research report issued on Wednesday, April 3rd, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock.

A number of other brokerages have also recently weighed in on SREN. UBS Group set a CHF 78 price target on shares of Swiss Re and gave the stock a “sell” rating in a research report on Thursday, January 3rd. Deutsche Bank set a CHF 100 price objective on shares of Swiss Re and gave the company a “buy” rating in a research report on Thursday, February 21st. Jefferies Financial Group set a CHF 93 price objective on shares of Swiss Re and gave the company a “neutral” rating in a research report on Wednesday, March 6th. Barclays set a CHF 98.60 target price on shares of Swiss Re and gave the company a “buy” rating in a research note on Wednesday, January 16th. Finally, Royal Bank of Canada set a CHF 98 target price on shares of Swiss Re and gave the company a “neutral” rating in a research note on Monday, March 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of CHF 103.79.

Swiss Re has a 12-month low of CHF 81.65 and a 12-month high of CHF 98.80.

Swiss Re Company Profile

Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.

See Also: Buyback

Analyst Recommendations for Swiss Re (VTX:SREN)

Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.